In a majority decision, the Advisory Committee on Mental Drugs cited concerns about the data presented on MDMA as a treatment for post-traumatic stress disorder.
FDA Committee Votes Against Approval of Lycos Therapeutics’ MDMA Drug for PTSD
Leave a comment
